Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CORVUS PHARMACEUTICALS, INC.

(CRVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 10716099,9190--
Entreprise Value (EV)1 -7,1316099,9190190190
P/E ratio -2,15x-3,42x-17,8x-4,66x-6,62x-5,73x
Yield ------
Capitalization / Revenue ----5,56x1,77x
EV / Revenue ----5,56x1,77x
EV / EBITDA -2 193 927x-----
Price to Book 0,92x-----
Nbr of stocks (in thousands) 29 28229 40528 06242 421--
Reference price (USD) 3,675,443,564,474,474,47
Announcement Date 03/07/201903/05/202003/25/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 ----34,1107
EBITDA -49,0-----
Operating profit (EBIT)1 -49,2-48,9-43,8-43,6-50,6-50,9
Operating Margin -----148%-47,5%
Pre-Tax Profit (EBT)1 -46,9-46,7-6,00-40,1-41,3-59,3
Net income1 -46,9-46,7-6,00-40,1-41,3-59,3
Net margin -----121%-55,3%
EPS2 -1,71-1,59-0,20-0,96-0,68-0,78
Dividend per Share ------
Announcement Date 03/07/201903/05/202003/25/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -9,88-11,5-11,3-10,1-10,8-30,6
Operating Margin ------
Pre-Tax Profit (EBT)1 27,3--11,8-8,95-8,05-
Net income1 27,3--11,8-8,95-8,05-
Net margin ------
EPS2 0,93-0,34-0,28-0,21-0,19-
Dividend per Share ------
Announcement Date 03/25/202104/29/202108/02/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position 115-----
Leverage (Debt / EBITDA) 2,34x-----
Free Cash Flow1 -41,3-36,6-15,036,043,0
ROE (Net Profit / Equities) -48,1%-----
Shareholders' equity1 97,6-----
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share 4,01-----
Cash Flow per Share -1,49-----
Capex1 0,360,03--1,001,00
Capex / Sales ----2,93%0,93%
Announcement Date 03/07/201903/05/202003/25/2021---
1 USD in Million
Key data
Capitalization (USD) 189 622 580
Number of employees 42
Free-Float 88,4%
Free-Float capitalization (USD) 167 616 846
Avg. Exchange 20 sessions (USD) 16 383 957
Average Daily Capital Traded 8,64%
EPS & Dividend